Napro A 500 mg Tablet
NAPRO-A (Naproxen) is a non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Naproxen is a propionic acid derivative and it inhibits the synthesis of prostaglandins, primarily by inhibiting the enzyme cyclo-oxygenase. It is widely used to treat patients with rheumatic diseases. NAPRO-A (Naproxen) is rapidly and completely absorbed from the gastrointestinal tract after oral administration.
Tablet 250: Each enteric-coated tablet contains Naproxen BP 250 mg.
Tablet 500: Each enteric-coated tablet contains Naproxen BP 500 mg.
NAPRO-A (Naproxen) is indicated for the treatment of primary dysmenorrhoea, rheumatoid arthritis, juvenile rheumatoid arthritis, osteoarthrosis (degenerative arthritis), ankylosing spondylitis, acute tendinitis, bursitis, acute gout and acute inflammatory musculoskeletal disorders.
DOSAGE AND ADMINISTRATION
Adults : 500 mg-1g daily in two divided doses or 1g once daily. In mild to moderate pain, dysme-norrhoea, acute tendinitis, bursitis and acute inflammatory musculoskeletal disorders: 500 mg initially, then 250 mg every 6-8 hours as required; maximum dose after first day 1.25 g daily.
Children under 16 years are not recommended.
Acute gout : 750 mg initially, then 250 mg every 8 hours until attack has passed.
Children under 16 years are not recommended. In Rheumatoid Arthritis, Osteoarthritis and Ankylosing Spondylitis : The recommended dose of NAPRO-A in adults is 250 mg or 500 mg twice daily.
Children (over 5 years) : In juvenile rheumatoid arthritis, 10 mg/kg body weight daily in two divided doses. Naproxen is not recommended for use in any other indications in children under 16 years of age.
OR AS DIRECTED BY THE PHYSICIAN.
Diarrhoea, dyspepsia, abdominal pain, nausea, constipation, and pruritus may occur. Heartburn, headache, dizziness, drowsiness may develop rarely.
Naproxen is contraindicated in patients with active peptic ulceration, severe renal impairment and hypersensitive to Naproxen or Naproxen Sodium formulations. Naproxen should not be given with a history of asthma, rhinitis or urticaria induced by aspirin or other non-steroidal anti-inflammatory drugs.
Naproxen should be given under close supervision to patients with history of gastrointestinal disease. As it is eliminated to a large extent (95%) by urinary excretion, it should be used with great caution in patients with impaired renal function.
Use in pregnancy and lactation
Safety for use during pregnancy has not been established, so, use is not recommended. The use of Naproxen should be avoided during lactation.
Tablet 250 : Each box contains 10x10 tablets in blisters.
Tablet 500 : Each box contains 3x10 tablets in blisters.